Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Immunol.

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1616414

This article is part of the Research TopicCommunity Series in Methods in Cancer Immunity and Immunotherapy: Volume IIView all 9 articles

Emerging Strategies in Colorectal Cancer Immunotherapy: Enhancing Efficacy and Survival

Provisionally accepted
Yu  ZhangYu ZhangHaixia  GuanHaixia GuanXixuan  FengXixuan FengMengyan  LiuMengyan LiuJinhuan  ShaoJinhuan ShaoMengchi  LiuMengchi LiuJialei  HeJialei HeYahui  JinYahui JinChunli  ZhengChunli Zheng*
  • Yan'an University, Yan'an, Shaanxi Province, China

The final, formatted version of the article will be published soon.

Colorectal cancer (CRC) is a prevalent malignancy of the digestive system, with metastatic CRC (mCRC) exhibiting persistently poor overall survival rates.Consequently, there is an urgent need to develop more effective and safer therapeutic strategies. In recent years, immunotherapy has emerged as a groundbreaking approach in CRC treatment. This review highlights the advancements in immune checkpoint Inhibitors (ICIs), cancer vaccines, oncolytic virotherapy, adoptive cell therapy(ACT), and matrix-depletion therapy. Additionally, we explore potential combinatorial immunotherapy strategies for CRC, emphasizing their clinical applications and addressing the challenges associated with CRC immunotherapy. By proposing strategies to overcome these limitations, this review aims to provide novel insights into the evolving landscape of CRC immunotherapy.

Keywords: colorectal cancer immunotherapy, immune checkpoint inhibitors, Cancer Vaccines, adoptive cell therapy, matrix-depletion therapy

Received: 22 Apr 2025; Accepted: 17 Sep 2025.

Copyright: © 2025 Zhang, Guan, Feng, Liu, Shao, Liu, He, Jin and Zheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Chunli Zheng, chunlizheng@126.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.